What is an Accelerated Share Repurchase (ASR) agreement?

An Accelerated Share Repurchase (ASR) agreement is a contract between a company and its bank or brokerage firm to buy back a significant amount of the company's own stock over a short period. The company typically pays the bank an agreed-upon amount, and the bank delivers a substantial portion of the shares immediately. The final number of shares repurchased is usually determined at the end of the agreement based on the average market price during that period.

Why would Edwards Lifesciences enter into an ASR agreement?

Companies typically enter into ASR agreements to return capital to shareholders efficiently, boost earnings per share (EPS) by reducing the number of outstanding shares, and signal confidence that management believes the company's stock is undervalued. It allows for a rapid reduction in share count compared to traditional open-market repurchases.

What is the potential impact of this ASR on EW's stock?

The ASR program is expected to reduce the number of outstanding shares, which can lead to an increase in earnings per share (EPS), potentially making the stock more attractive to investors. The announcement itself can also create positive sentiment. However, the ultimate impact depends on the size of the repurchase, the prevailing stock price, and the company's overall financial performance.

Where can I find more information about the ASR agreement?

More detailed information regarding the terms and expected impact of the Accelerated Share Repurchase agreement can be found in the press release issued by Edwards Lifesciences on August 19, 2025, which is included as Exhibit 99.1 in this 8-K filing.

EW 8-K SEC Disclosure — Aug 19, 2025

Summary

Edwards Lifesciences Corporation (EW) has announced its entry into an accelerated share repurchase (ASR) agreement, as detailed in an 8-K filing dated August 19, 2025. This strategic move indicates the company's commitment to returning capital to shareholders and reflects management's confidence in the company's financial health and future prospects. Investors should note that ASR agreements typically involve repurchasing a significant amount of stock in a short period, which can positively impact earnings per share and signal a belief by the company that its stock is undervalued. The press release filed as Exhibit 99.1 provides further details on the terms and expected impact of this repurchase program.

Key Highlights

1Edwards Lifesciences (EW) entered into an Accelerated Share Repurchase (ASR) agreement.
2The announcement was made via a press release filed with the SEC on August 19, 2025.
3The ASR agreement signifies a capital return initiative to shareholders.
4This action may suggest management's positive outlook on the company's stock valuation.
5The ASR program is expected to impact the number of outstanding shares.
6Further details on the agreement are available in the incorporated press release (Exhibit 99.1).

Edwards Lifesciences Corp 8-K Report, Corporate Update (Aug 19, 2025)

Summary

Key Highlights

Frequently Asked Questions